Vaccinex Files 8-K for 'Other Events' and Financial Exhibits
Ticker: VCNX · Form: 8-K · Filed: Feb 21, 2024 · CIK: 1205922
| Field | Detail |
|---|---|
| Company | Vaccinex, Inc. (VCNX) |
| Form Type | 8-K |
| Filed Date | Feb 21, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, other-events
TL;DR
**Vaccinex just dropped an 8-K for 'Other Events' and financials, keep an eye out for details!**
AI Summary
Vaccinex, Inc. filed an 8-K on February 21, 2024, reporting an 'Other Event' and 'Financial Statements and Exhibits'. The filing indicates a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The company, incorporated in Delaware with IRS Employer Identification No. 16-1603202, maintains its principal executive offices at 1895 Mount Hope Avenue, Rochester, New York 14620.
Why It Matters
This routine 8-K filing signals that Vaccinex, Inc. has an event or information deemed significant enough to warrant immediate disclosure to investors, potentially impacting market perception or future financial analysis.
Risk Assessment
Risk Level: low — This 8-K is a standard disclosure of an 'Other Event' and financial exhibits, which is a routine filing and does not inherently indicate high risk without further context.
Key Players & Entities
- VACCINEX, INC. (company) — Filer of the 8-K
- February 21, 2024 (date) — Date of earliest event reported and filing date
- Delaware (company) — State of incorporation for Vaccinex, Inc.
- 1895 Mount Hope Avenue, Rochester, New York 14620 (company) — Address of principal executive offices for Vaccinex, Inc.
- 16-1603202 (company) — IRS Employer Identification No. for Vaccinex, Inc.
FAQ
What is the purpose of this 8-K filing by Vaccinex, Inc.?
This 8-K filing by Vaccinex, Inc. is a 'Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934' and reports 'Other Events' and 'Financial Statements and Exhibits'.
When was the earliest event reported in this 8-K?
The earliest event reported in this 8-K occurred on February 21, 2024.
Where are Vaccinex, Inc.'s principal executive offices located?
Vaccinex, Inc.'s principal executive offices are located at 1895 Mount Hope Avenue, Rochester, New York 14620.
What is Vaccinex, Inc.'s state of incorporation?
Vaccinex, Inc. is incorporated in Delaware.
What is the Commission File Number for Vaccinex, Inc.?
The Commission File Number for Vaccinex, Inc. is 001-38624.
Filing Stats: 414 words · 2 min read · ~1 pages · Grade level 10.9 · Accepted 2024-02-21 10:10:30
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share VCNX Nasdaq Capital Marke
Filing Documents
- d781705d8k.htm (8-K) — 25KB
- d781705dex991.htm (EX-99.1) — 10KB
- g781705dsp_1bb.jpg (GRAPHIC) — 9KB
- 0001193125-24-040885.txt ( ) — 167KB
- vcnx-20240221.xsd (EX-101.SCH) — 3KB
- vcnx-20240221_lab.xml (EX-101.LAB) — 17KB
- vcnx-20240221_pre.xml (EX-101.PRE) — 11KB
- d781705d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release, dated February 21, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VACCINEX, INC. Date: February 21, 2024 By: /s/ Maurice Zauderer Maurice Zauderer, Ph.D. President & Chief Executive Officer